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Involvement of interleukin 2 receptors in conceptus-derived
suppression of T and B cell proliferation in horses
T. L. Roth, K. L. White,
1

D. L. Thompson, Jr, S. Rahmanian and
D. W. Horohov

Department of Animal Science, Louisiana Agricultural Experiment Station, LSU Agricultural
Center; and 2Department of Microbiology and Parasitology, School of Veterinary Medicine,
Louisiana State University, Baton Rouge, LA 70803, USA

Summary.

The mechanism by which a horse conceptus-derived immunosuppressive
> 100 000 inhibits lymphocyte proliferation was investigated. The
was obtained from the culture supernatants of 20-day-old horse conceptuses;
activity, identified by reduced uptake of [3H]thymidine by mitogen-stimulated lymphocytes, was greatest (P < 0\m=.\01)in cultures stimulated by mitogen from pokeweed. HCS
also suppressed cell proliferation stimulated by phytohaemagglutinin (P < 0\m=.\01),but had
no effect on lipopolysaccharide-stimulated cells (P > 0\m=.\05).Data from a fluorescence\x=req-\
activated cell sorter indicated that supplementation with HCS reduced the number of
T cells in phytohaemagglutinin-stimulated cultures and suppressed proliferation of T and
B cells in pokeweed-mitogen-stimulated cultures compared with controls. Cell proliferation was greater (P < 0\m=.\01)in cultures supplemented with HCS 24 h after stimulation
than in those treated at the start of stimulation, and was even greater (P < 0\m=.\01)when
cells were treated 48 h after stimulation. The removal of HCS from treated lymphocyte
cultures resulted in complete recovery of cell responsiveness, and stimulated proliferation of treated cells did not differ (P > 0\m=.\05)from that of control cells. The addition of
stimulated equine lymphocyte supernatant to cultures supplemented with HCS did not
significantly increase (P > 0\m=.\05)cell proliferation in response to pokeweed mitogen.
Addition of recombinant human interleukin 2 (rIL-2) to HCS-treated cultures did not
alter the suppressive activity of HCS, although cell proliferation was greater in cultures
supplemented with rIL-2 than in controls (P < 0\m=.\01).HCS inhibition of IL-2 receptor
(IL-2R) function was investigated using an IL-2-dependent murine cytolytic T lymphocyte
cell line; the fraction of HCS of Mr > 100 000 had no effect (P > 0\m=.\05)on proliferation of
IL-2-dependent murine cytolytic T lymphocyte cells induced by rIL-2. Together, these
data suggest that HCS suppresses proliferation of T lymphocytes during the early stages of
cell activation by inhibiting IL-2R interaction and that this suppression interferes with
interactions between T cells and B cells, thereby also indirectly inhibiting proliferation of
B cells. The potent immunosuppressive capacity of HCS may be one factor responsible
for inhibiting cell-mediated fetal allograft rejection during pregnancy.
factor
factor

(HCS) of Mr
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Introduction
A 30 000 kDa factor in medium conditioned by horse conceptuses has shown immunosuppressive
activity (Roth et al, 1990). Roth et al. (1991) have shown that this suppressor factor, horse
*Present address and reprint requests: Department of Animal,
Utah State University, Logan, UT 84322-4815, USA.
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conceptus-derived immunosuppressive factor (HCS) has M, > 100 000. High Mr components of
cultures of conceptuses and of gravid uterine fluid of other domestic species, such as cows (Segerson
& Bazer, 1989), sheep (Hansen et al, 1987; Murray et al, 1987) and pigs (Murray et al, 1987), also
suppress lymphocytes when used to supplement blastogenesis cultures in vitro. These suppressive
factors may play a role in protecting the conceptus from maternal immunological attack during
pregnancy. In horses, one such role may be to aid the temporary protection of the endometrial
cups, which, although surrounded by lymphocytes, are not destroyed until day 120 of pregnancy
(Allen, 1979). Most investigations have been directed towards identifying and characterizing
uterine and conceptus-derived factors (Murray et al, 1978; Godkin et al, 1982; Hansen et al, 1987;
Newton et al, 1988; McDowell et al, 1990), but their functional significance is largely unknown.
Immunosuppressive mechanisms of components obtained from uterine fluid or conceptus tissue
has been reported for humans (Pockley & Bolton, 1990; Saito et al, 1990), mice (Clark et al, 1985;
Mayumi et al, 1985; Clark et al, 1986), sheep (Segerson, 1988) and, more recently, cows (Segerson
& Libby, 1990). In these studies, suppressor activity was identified in lymphocyte cultures as
reduced uptake of [3H]thymidine by cells after mitogen stimulation. Some mitogens selectively
stimulate
cells (Sharon, 1983), but in most immunosuppressive studies only phytoor
a
haemagglutinin, potent T-cell activator, has been used to stimulate lymphocyte proliferation.
Because cell-mediated immunity is of greater concern than humoral immunity in fetal allograft
acceptance, cells have been the focus of most attempts to elucidate suppressor factor mechan¬
isms. The production of interleukin 2 (IL-2) and the expression of the high-affinity IL-2 receptor
(IL-2R) are critical for proliferation of cells in response to either phytohaemagglutinin or antigen
(Depper et al, 1984). Data from several experiments indicate that IL-2 production, IL-2R expression
and their interaction are disrupted by conceptus- or uterine-derived suppressor factors in many
species, including mice (Clark et al, 1985, 1986), humans (Saito et al, 1990; Menu & Chaouat,
1989), sheep (Segerson, 1988) and cows (Segerson & Gunsett, 1990; Segerson & Libby, 1990).
Although results from mitogen-stimulated lymphocyte proliferation assays have provided valu¬
able information about the response of these cells to immunosuppressive factors in vitro, the
responses of specific cell subsets have not been determined. Antibodies to unique cell subset anti¬
gens (CD4, CD5 and CD8) are available for labelling selective cell populations. Antibodies to
equine lymphocytes bind either the entire T-cell population or a subset of suppressor cells (Wyatt
et al, 1988). Specific fluorescent antibody labelling followed by fluorescence-activated cell sorter
(FACS) analysis provides an accurate method for immunophenotypically distinguishing and
quantifying cell subsets in a mixed cell population (Jackson & Warner, 1986).
The experiments described were designed (i) to examine the effect of HCS on and cells using
various mitogens and FACS analysis; (ii) to determine the temporal relationship of HCS activity
and lymphocyte activation and (iii) to define the proposed IL-2 associated mechanism of
lymphocyte suppression more clearly.

Materials and Methods
Animals and conceptus cultures

breeding regimen and conceptus collection techniques were as described by Roth et ai (1990). Briefly,
collected by non-surgical uterine flushing on day 20 (ovulation on day 0) using sterile phosphatebuffered saline (PBS) supplemented with either 1% calf serum (Hyclone, Logan, UT) and 1% antibiotic/antimycotic
(group 1), or only 1% antibiotic/antimycotic (group 2). Under sterile conditions, conceptuses were rinsed twice in
their respective medium, after which group 1 conceptuses were rinsed once in RPMI-1640 (Gibco, Grand Island, NY)
supplemented with 15% fetal calf serum (FCS; Hyclone, Logan, UT; non-heat-treated, <0T ng ml"1 endotoxin)
and 1% antibiotic/antimycotic (RPMI + ), and group 2 conceptuses were rinsed in RPMI-1640 with 1% antibiotic/
antimycotic (RPMI). The three group 1 conceptuses were each placed in a 50 ml tissue culture flask containing 20 ml
RMPI +. Cutlures were incubated for 48 h at 37°C in a humidified atmosphere of 5% C02 in air. The three group 2
conceptuses were each placed in a 50 ml tissue culture flask containing 15 ml RPMI and were incubated for 30 h under
the same conditions described for group 1. Conceptus culture supernatants from each group were pooled (HCS 1 and
The horse

conceptuses

were
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HCS 2), centrifuged (600 g for 20 min), filtered (0-2 µ ) and stored in aliquots at 80°C. A lymphocyte proliferation
assay was used to determine that there was no difference (P > 0-05) in suppressive activity between HCS 1 and HCS 2.
Control medium (CM) consisted of RPMI or RPMI + incubated, filtered and stored in a similar way.
For some experiments. HCS and CM samples were fractionated by centrifugation through microconcentrators
with M, 100 000 exclusion membranes (Amicon, Danvers, MA). Retentate fractions were rinsed twice and
resuspended to their 'original volumes with RPMI-1640. Both fractions of CM and HCS were filtered (0-2 µ ) and
diluted to 600 µ
in RPMI +
—

.

Assays of lymphocyte proliferation
Unless otherwise stated, the horse lymphocyte proliferation assays were carried out as follows. Whole blood was
obtained from mares by jugular venepuncture. Peripheral blood lymphocytes were isolated by Ficoll-gradient
centrifugation according to McClure et ai (1978), resuspended in RPMI + counted on a haemocytometer and diluted
106 cells ml-1. Cultures were prepared in quadruplicate for each peripheral blood
to a final concentration of 4
lymphocyte population in 96-well round-bottomed tissue culture-treated plates (Corning Glass Works, Corning, NY,
USA), each well receiving 1 10s cells (25 µ ). The mitogens phytohaemagglutinin, pokeweed and lipopolysaccharide
cell proliferation. Maximum pro¬
(Sigma, St Louis, MO, USA) were diluted in RPMI-1640 and added to stimulate
liferation was induced by 10 µg phytohaemagglutinin ml" ', 1 µg pokeweed ml" ' and 0^g lipopolysaccharide ml" '
(final concentration in cultures). HCS or fractionated HCS was added in concentrations specified for each assay, and
final well volume was 100 µ . Cultures were maintained at 37°C in a humidified atmosphere of 5% C02 in air for 80100h before addition of [3H]thymidine (1 µ per well; 6-7CÌ mmol-1, ICN, Irvine, CA, USA). After an additional
16 + 2 h of culture, cells were harvested onto glass fibre filters using a Skatron automatic cell harvester (Flow
Laboratories, Rockville, MD, USA). Radioactivity on the filters was determined by liquid scintillation counting.
,

Preliminary assays
The concentrations of phytohaemagglutinin required to induce suboptimal proliferative responses were deter¬
mined by testing three peripheral blood lymphocytes samples with serial dilutions of phytohaemagglutinin (300-625 µg ml"1). Maximum cell proliferation was achieved at a concentration of 10 µg ml"1 while a suboptimal
response (approximately 50% of maximum) was obtained at 1 -25 µg ml '.
The suppressive potential of HCS in antigen-specific lymphocyte responses was investigated by adding HCS to
two-way mixed lymphocyte reactions to ensure that components of HCS were not simply binding to the mitogens and
thereby suppressing lymphocyte activation. The assays were carried out as described above except 3 IO5 cells from
each of two unrelated mares were added to the wells in the absence of any mitogen. A total of six different two-way
mixed lymphocyte reactions were carried out and the results, following the addition of 0, 10 and 20 µ per well HCS,
were 81 361 + 8190, 53 441 ± 5392 and 33 594 + 3317 (mean c.p.m. ± SEM), respectively.
~

Mitogen comparison assay
The suppressive activity of HCS 2 on lipopolysaccharide- phytohaemagglutinin- and pokeweed-mitogenstimulated lymphocytes was compared. HCS 2 was serially diluted in RPMI + such that treated wells contained HCS 2
at 20-1-25% of total volume, whereas control wells received only RPMI + Phytohaemagglutinin was added at the
sub-optimal dose (l 25µg ml"1) to increase the sensitivity of the phytohaemagglutinin-treated cells to HCS sup¬
pression. The three mitogen assays were run simultaneously with peripheral blood lymphocytes from three randomly
chosen mares. One week prior to lymphocyte collection, these mares had received an equine encephalomyelitis vacci¬
nation which is standard practice management in this area. Phytohaemagglutinin- and pokeweed-mitogen-stimulated
cultures were pulsed with 3H[thymidine] at 80 h and harvested at 96 h; lipopolysaccharide-stimulated cultures were
pulsed at 96 h and harvested at 112 h since we found lipopolysaccharide-treated cells require more time to achieve
their maximum proliferative response.
.

Temporal effect of HCS
The stage of cell activation at which HCS interferes was determined by adding HCS 1 to lymphocyte cultures 0, 24
and 48 h after pokeweed mitogen stimulation of cells. The lymphocyte proliferation assay was prepared as previously
described using lymphocytes from three randomly chosen mares. On the 96-well plate, triplicate rows were designated,
time 0, time 24 and time 48. HCS 1 was serially diluted in RPMI + to three final concentrations of 480, 240 and 120 µ
ml"1. Each of the time 0 rows were supplemented with a different dilution of HCS 1 (25 µ per well). After 24 h
incubation, each of the three time 24 rows received 25 µ per well of the same three HCS 1 dilutions. At 48 h the three
time 48 rows were similarly supplemented. At each treatment period, those wells not receiving HCS 1 received 25 µ
RPMI + such that final volume in all wells was 150 µ . Pokeweed mitogen was supplemented to all wells except the
non-stimulated control at time 0. All wells were pulsed at 100 h and harvested at 116 h. This experiment was
repeated with a total of six peripheral blood lymphocyte populations, and data from both experiments were pooled
for statistical analysis.
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Cells were treated with HCS 2 before mitogen stimulation to determine whether HCS-treated lymphocytes are
permanently suppressed. Peripheral blood lymphocytes from two mares were prepared as described for the lympho¬
cyte proliferation assays. The pre-stimulated cultures consisted of four treatments set up in sterile cryovials as follows:
(i) non-stimulated 150 µ cells + 450 µ RPMI + ; (ii) control 300 µ cells + 900 µ RPMI + : (iii) HCS 10 120 µ
HCS 2 + 300 µ cells + 780 µ RPMI + ; (iv) HCS 5 60 µ HCS 2 + 300 µ cells + 840 µ RPMI + Vials were
-

-

-

vortexed and incubated at 37°C with loosened caps for 24 h. At the end of incubation, cells were washed twice in
RPMI + (400g for 10min) and resuspended at 2
106cells ml"'. Cells from each prestimulated culture were
pipetted into wells (50 µ per well) and treated with 25 µ RPMI+ containing 0 µ (pretreated only cells), 5 µ
(pre/post-treated 5) or 10 µ (pre/post-treated 10) HCS 2. Pokeweed mitogen was added to all wells except the
non-stimulated controls and the assay completed as previouly described.
-

.

Supplementation with equine lymphocyte supernatant
Equine peripheral blood lymphocyte supernatant was generated by combining peripheral blood lymphocytes from
106 ml"1 (10 ml total), adding 100µg phyto¬
mares, diluting cells in RPMI+ to a concentration of 5
haemagglutinin, incubating for 6 h at 37°C and centrifuging at 400 g for 10 min. The cells were resuspended in 10 ml
fresh RPMI + incubated for 18 h and again centrifuged at 600 # for 10 min to obtain peripheral blood lymphocyte
supernatant. Control medium (CM) consisted of 10 ml of the same RPMI + incubated for 18 h. The peripheral blood
lymphocyte supernatant assay was prepared with three lymphocyte populations. Two 96-well plates were set up with
10s per well), and pokeweed mitogen
serial dilutions of HCS 2 (10-0-625 µ per well). Cells were added to wells (1
was added to all wells except the non-stimulated controls. All wells of one plate received 50 µ peripheral blood
lymphocyte supernatant, whereas all wells of the second plate received 50 µ CM. After 24 h of culture, all wells
received another 40 µ of their respective medium, bringing the total well volume to 150 µ and the assay was
completed as previously described.
three

,

Supplementation with IL-2
Because recombinant human interleukin-2 (rIL-2) will interact with horse IL-2R (Fenwick et ai, 1988), rIL-2
(Cetus Corp., Emeryville, CA) was used in two assays designed to determine whether supplementation of IL-2 to
HCS-treated lymphocytes would override the suppressive effect of HCS. Peripheral blood lymphocytes from three
mares were used. In the first experiment, two sets of quadruplicate wells of each peripheral blood lymphocyte popu¬
lation were supplemented with 3, 6, 12 and 24 µ of HCS 1. One set of each quadruplicate pair also received rIL-2
(200 U ml" ). Suboptimal phytohaemagglutinin was added to all wells.
In the second experiment, HCS 2 was added to cultures at 15% of well volume and cell proliferation was stimu¬
lated with the suboptimal dose of phytohaemagglutinin. Serial dilutions of rIL-2 (50-0-78 U ml" !) were also added to
cultures. Non-stimulated cells were supplemented with rIL-2 as controls. The positive control consisted of cells,
phytohaemagglutinin and rIL-2, but no HCS.

IL-2-dependent murine cytolytic T-lymphocyte cell line (CTLL-2 cells).
Unlike resting lymphocytes, CTLL-2 cells continuously express the high-affinity IL-2R complex and the addition
of small concentrations of IL-2 will immediately stimulate these cells to proliferate, whereas a deficiency of IL-2 will
lead to their rapid demise (Gillis et ai, 1978). The effect of HCS on IL-2R function was investigated by adding
fractionated HCS 2 to CTLL-2 cell cultures. Triplicate wells in each row of a 96-well plate were prepared with four serial
dilutions of rIL-2 (12-5 to 1 -56 U ml '). One row served as a standard and each well received 50 µ of RPMI +, the wells in
the remaining rows received one of the two fractions of HCS 2 or CM (20% of final well volume). CTLL-2 cells were added
to all wells (2000 cells per well) and cultures were incubated for 24 h before pulsing with [3H]thymidine ( \iC\ per well).
Cultures were harvested 4 h after pulsing and radioactivity was determined by liquid scintillation counting.
"

Mouse

splenocytes

Mouse splenocytes, obtained from spleen homogenates by Ficoll-gradient centrifugation, were rinsed twice with
Hank's balanced salt solution (HBSS; Hyclone, Logan, UT) and resuspended in RPMI+ at 7
106 cells ml"1.
Splenocytes were added to two 96-well plates in 25 µ and were stimulated by the addition of 50 µ pokeweed mitogen,
phytohaemagglutinin or Concanavalin A (ConA; Sigma, St Louis, MO) at 5, 2-5 and 5 µg ml" ', respectively (final
concentration in wells). Fractionated HCS 2 was added to treated wells of one plate (20% of well volume), whereas
stimulated control wells received the same volume of each CM fraction. Cells were pulsed at 88 h and harvested at
100 h.

FACS

analysis

FACS analysis was used to determine the effect of HCS 2 on proliferation of specific lymphocyte subsets. HCStreated cell populations were compared with non-treated cells using three antibodies to different equine lymphocyte
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markers. The monoclonal antibodies (mAb) HT23A and HT14A (pan-T and T-suppressor-cell subset antibodies,
respectively; VMRD, Pullman, WA), and a fluorescein isothiocyanate (FITC)-conjugated polyclonal goat anti-equine
IgG antibody (B-cell antibody) were used. The conjugate for the mAbs was an FITC-conjugated goat anti-mouse IgG
antibody (VMRD, Pullman, WA). Two equine peripheral blood lymphocyte populations were analysed. For each
population, five tissue culture flasks were prepared as follows: (i) Control 4 ml RPMI + ; (ii) phytohaemagglutinin
phytohaemagglutinin + 4 ml RPMI + ; (iii) pokeweed pokeweed mitogen + 4 ml RPMI + ; (iv) phytohaemaggluti¬
nin-!- phytohaemagglutinin + 500µ HCS 2 + 3-5ml RPMI + ; (v) pokeweed+ pokeweed mitogen + 500µ
HCS 2 + 3-5 ml RPMI + To each flask, 1 ml of cells suspended in RPMI+ at 5
IO6 cells ml"1 was added; flasks
were incubated for 96 h and cell concentration was determined using a haemocytometer. The cell
suspension in each
flask was divided into five sterile tubes (1 ml per tube): (1) autofluorescent control, (2) FITC control, (3) mAb HT23A,
(4) mAb HT14A and (5) IgG-FITC. The cells were pelleted (400 £ for 10 min) and rinsed with 3 ml PBS. The mono¬
clonal antibodies, HT23A and HT14A, were diluted 1:1000 in PBS supplmented with 10% goat serum (PBS-GS),
whereas the polyclonal goat anti-equine IgG-FITC and goat anti-mouse IgG-FITC antibodies were diluted 1:400 in
PBS-GS. They were then added to appropriate tubes (50 µ per tube); the autofluorescent and FITC controls received
50 µ cold PBS-GA and the tubes were vortexed and incubated on ice for 1 h. All samples were washed with 3 ml ice
cold PBS-GS and after decanting, 75 µ cold 1 % p-formaldehyde was added to the IgG-FITC tubes to fix cells, which
were then vortexed and stored at 4°C. All remaining tubes, except the autofluorescent controls, received 50 µ of
diluted goat anti-mouse IgG-FITC; autofluorescent controls received 50 µ PBS-GS. After vortexing, cells were incu¬
bated on ice for I h, then washed and fixed as described for the IgG-FITC tubes. Samples were stored at 4°C for 48 h,
then diluted with 100 µ PBS-EDTA and analysed on a FACS 440 (Becton Dickinson, Mountain View, CA). For each
sample, 10 000 cells were analysed for both fluorescence and light scatter using a Consort 40 analyser (Becton
Dickinson, Mountain View, CA). Gate settings were determined on the basis of autofluorescent and FITC controls to
eliminate any non-specific or background fluorescence. Owing to between-flask variation in cell concentration follow¬
ing the 96 h culture, data were recorded as average cell number ml" ' (final cell concentration in flask % of 10 000
labelled) such that results for a specific cell population would not be biased by a change in the size of other cell subset
populations. The two-dimensional scatter analysis was used to compare blast cell populations between treatments.
The percentage of blast cells was determined by comparing stimulated with non-stimulated FITC control samples.
Gates were set such that the windowed area contained the larger cells present only in the stimulated samples. A
window with the same gate settings was then applied to the HCS-treated, stimulated samples, and the percentage of
cells (blast cells) in this area was recorded.
=

=

-

=

=

.

Statistical

analysis

and percentage of stimulated control (average c.p.m. of experimental cultures/
average c.p.m. of stimulated control cultures
100) for triplicate or quadruplicate wells of proliferation assays were
determined. Statistical analysis was performed using data recorded as c.p.m. if the stimulated control values were the
same for the treatments being tested. If the stimulated control values differed among treatment groups, data were
expressed and analysed as percentages of stimulated control. Results, in the appropriate form for each assay, were
analysed in a factorial arrangement by anova using the general linear model procedures of the statistical analysis
systems (SAS) computer package (Luginbuhl et ai, 1985). All main effect interactions were tested (i.e. treatment or
time HCS or rIL-2 dose). Between-treatment groups and within treatment differences were determined by Tukey
mean comparison tests. The effects of rIL-2 on HCS-treated cells and untreated cells were
compared by carrying out
regression analysis with data in each of the two rIL-2 supplementation assays. Treatment curves were compared and
tested for differences in intercepts, linear functions and quadratic functions, and insignificant terms were dropped
from the model.

Average radioactivity (c.p.m.)

=

Results

Mitogen comparison
The effect of HCS on lymphocyte cultures differed (P < 0-01) depending on the mitogen used to
stimulate lymphocyte proliferation (Table 1). The results of a 3 6 factorial arrangement anova
and Tukey mean comparisons showed that, compared with stimulated controls, the percentage
suppression of HCS-treated cell proliferation was greater (P < 001) in pokeweed-mitogenstimulated cultures than in lipopolysaccharide- and phytohaemagglutinin-stimulated cultures.
Phytohaemagglutinin-stimulated cells were suppressed (P < 0-01) by high concentrations of HCS
(10 and 20 µ per well), but lipopolysaccharide-stimulated cells were unaffected (P > 005) at all
concentrations of HCS (within mitogen Tukey mean comparisons). Non-stimulated control values
were significantly greater in the phytohaemagglutinin and pokeweed stimulated assays, probably
owing to vaccines received by the horses 1 week before lymphocyte collection.
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Table 1. Effect of horse conceptus conditioned medium 2
stimulated lymphocytes in horses

per

on

mitogen-

Mitogen

HCS 2

(µ

(HCS 2)

Phytohaemagglutininb

Lipopolysaccharide"

well)

0 (control)
1-25
2-5
5

21 184 ±
20 180 ±
19 446+
18 799 +
20 700 ±
19 187 ±

10
20

2713
3553
788
1420
1117
682

76648
72 660
72 762
68 037
58 726
48 905

+ 18 131
+ 17 789

± 16 364
± 14010
+ 13 552*
+ II 160*

Pokeweed

mitogen0

77111 +
63 138 ±
43 365 +
30 595 ±
22 271 ±
12 155+

19572
13418*
9 260*
5 274*
2 677*
1094*

Values are

mean c.p.m. ± sem for three lymphocyte populations. Non-stimulated values for
lipopolysaccharide, phytohaemaglutinin and pokeweed mitogen were 8990 + 822,
5657 ± 578 and 14 712 ± 843, respectively.
a"'Different superscripts designate between-mitogen differences in overall suppressor ac¬
tivity (P < 001 ) as determined by Tukey mean comparisons using data expressed as % of
control. There was a significant mitogen HCS interaction ( < 001).
Differs from control (P < 001); within mitogen Tukey mean comparisons.

Temporal effect of HCS
Suppressive activity of HCS decreased ( < 0001) if HCS 1 was added to lymphocyte cultures
after the start of pokeweed mitogen stimulation (Fig. 1). Although still suppressive, HCS added to
cultures 24 h after the start of stimulation was less (P < 001) effective than if added at time 0. By
48 h after cell stimulation, the addition of HCS to the cultures resulted in only a slight decrease in
proliferation, much less ( < 001) than that observed when HCS was added at time 24. There were
no main effect interactions (P > 005).
120

-,

100
o
o

40

5

10

15

(µ per well)
Fig. 1. Effect of supplementation with horse conceptus conditioned medium 1 (HCS 1)
HCS1

on

pokeweed-mitogen-stimulated horse lymphocyte cultures at 0 ( ),

24 ( ) and 48 (·) h after
the start of culture. Values represent mean % of stimulated control + sem for betweenlymphocyte variation (n 6). Overall differences in suppression between all times evaluated
were observed (P < 001; Tukey mean comparisons). There were no significant interactions
=

(P

>

005).

Lymphocytes treated with HCS 2 could respond maximally to pokeweed mitogen stimulation
(Fig. 2). Proliferation of cultures pretreated with 5 or 10 µ HCS per well did not differ ( > 005)
from that of the stimulated control. However, the proliferative response of pretreated cells to which
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5 and

µ

lation)

was

per well HCS
much less (

again added during mitogen stimulation (before and during stimu¬
001) than that of both the pretreated only cells and the stimulated

was

<

control.

80

E
.

o

5

ro

20-

0

5

HCS2

10

well)
stimulation
after
incubation
of
horse
to
2.
lymphocytes with horse conceptus
Fig. Response
conditioned medium 2 (HCS 2). Values represent mean c.p.m. + sem for two lymphocyte
populations. Compared with the stimulated control (no HCS; ), there was no difference
( > 005) in the proliferative responses of cells treated with HCS 2, washed and subsequently
stimulated (D), while the responses of cells treated with HCS 2 before and during stimulation
(E3) were suppressed (P < 001). Different superscripts denote differences in [3H]thymidine

incorporation (P

<

(µ

per

001; Tukey mean comparisons).

Equine cell supernatant and IL-2 supplementation

Phytohaemagglutinin-stimulated peripheral blood lymphocyte supernatant was added to HCS
equine lymphocytes in an attempt to augment their proliferative response to pokeweed
mitogen, but compared with proliferation in control medium-supplemented cultures, there was no
difference (P > 005) in suppressive effect of HCS 2. The addition of an extremely high concen¬
tration of rIL-2 (200 U ml"1) to HCS 1-treated cells did not override the suppressive activity of
HCS 1. Although proliferation in cultures supplemented with rIL-2 was greater (P < 001) than
that in cultures without rIL-2, a dose-dependent decrease in proliferation with the addition of HCS
2-treated

in cultures with 200 U ml"1 rIL-2 (P < 001). Furthermore, results from the
that both treatment curves were linear with the same slope (P > 005;
ANOR; y 86-37-2-92*; R2 0-84) and only the intercepts were different (P < 0-01). Similarly,
regression analysis was used to determine that the slopes of the two treatment curves, phyto¬
haemagglutinin and phytohaemagglutinin + HCS, were linear and did not differ ( > 005)
(Fig. 3). Again, only the intercepts were different (P < 001). The results of the 3x7 factorial
anova and Tukey mean comparisons showed that overall proliferation in HCS 2-treated cultures
was less (P < 001) than that in phytohaemagglutinin control cultures, but greater (P < 001) than
that in nonstimulated cultures.
was

observed

even

regression analysis showed
=

=
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rIL-2 (U ml

Fig. 3. Effect of recombinant human interleukin-2 (rIL-2) supplementation on non-stimulated
( ) cells and on cells stimulated with phytohaemagglutinin (O), and treated with phyto¬
haemagglutinin plus HCS 2(A). Data represent mean c.p.m. + sem for between-lymphocyte
population variation (n 3). Supplementation with rIL-2 increased (P < 0-01) proliferation
of cells within each treatment. Between-treatment differences (P < 0-01; Tukey mean
comparisons) in overall [3H]thymidine incorporation was noted in all treatments tested.
Whereas the intercepts of all three treatment curves differ (P < 0-01), the linear slopes of the
phytohaemagglutinin and phytohaemagglutinin plus HCS 2 curves are the same (P > 0-05;
ANOR; R2 0-84).
=

=

CTLL-2 cells and murine

splenocytes

CTLL-2 cell proliferation in response to exogenous rIL-2 was not affected by the addition of the
Mr> 100 000 fraction of HCS, or the two fractions of CM (Table 2). However, the MT < 100 000
fraction of HCS did inhibit CTLL-2 proliferation (P < 001). While there was no effect of rIL-2
concentration (P > 005) except in the standard dose response, only in the standard did a decrease
in rIL-2 result in a significant decrease in cell proliferation (P < 005). HCS appeared to be effective
in suppressing pokeweed-mitogen-stimulated murine splenocytes as incorporation of [3H]thymidine
was less (P < 001) in cultures treated with the Mx > 100 000 HCS fraction than that in cultures
treated with the Mr > 100 000 CM fraction. However, there were no differences in proliferation
between treatments with concanavalin A or phytohaemagglutinin (P > 005).

FACS analysis
Because of the 96 h culture period before cell labelling and fixing, the cell concentration in each
106 ml"l: there was a decrease in cell number in the control flask
flask differed from the initial 1
and an increase in the mitogen-stimulated flasks. For this reason, the data are presented as final cell
numbers ml"1. Relative to non-stimulated controls, there was an increase in total cells with
both phytohaemagglutinin and pokeweed mitogen stimulation ( + 36 000 and + 11 000 cells ml" ',
respectively) (Table 3). However, a more exaggerated increase in cells was observed with both
mitogens ( + 238 000 and +236000cells ml"1, respectively). The addition of HCS to phyto¬
haemagglutinin-stimulated cells resulted in a decrease of 66 000 and 20 000 cells ml-1
compared with phytohaemagglutinin-stimulated cells without HCS. When HCS was added to
pokeweed mitogen-stimulated cells, a decrease in cells also occurred (— 19 000 cells ml" ·) and an
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Table 2. Effect of fractionated horse conditioned medium 2 (HCS 2) and control medium
(CM) on IL-2-dependent murine cytolytic lymphocyte cell line (CTLL-2) and murine

splenocytes

IL-2 induced
CTLL-2 proliferation
Standard
rlL^ÍUml"1)

12-5
6-25
3-125
1-56

13-41
13-48
13-42
10-70

CM

HCS2a

<100b

± 0-45
± 0-66
± 0-51

6-28
6-69
6-49
5-80

+ 0-48*

± 1-08
± 019
+ 0-42
+ 1-14

>100c

13-44
13-68
13-38
11-21

Mitogen stimulated proliferation of murine spenocytesd
< 100
Mitogen
Pokeweed mitogen
Concanavalin A

28-20 ± 2-03
52-49 + 7-21
13-23 + 1-78

Phytohaemagglutinin

+ 1-52
± 0-69
+ 0-77
+ 0-98

>

<100c

10-45
1303
10-34
9-05

100

2-79 + 0-52*
26-45 + 6-76
16-50 + 3-14

>100c

± 0-96
± 0-51

11-55
13-89
12-23
11-98

+ 0-88
+ 0-86

± 0-17
± 0-68
+ 0-82
+ 018

<100

>100

32-67 ± 4-96
48-32 + 8-35
19-44 + 4-71

40-28 ± 1-53
36-59 + 9-76
18-24 + 4-78

Values are c.p.m. + sem(x 10"3) for triplicate wells.
aHCS 2 and CM were separated into two fractions, M, < 100 000 and > 100 000 as indicated by < 100 and
> 100, respectively. Cultures at 20% of volume were supplemented with sample fractions.
bcDiflerent superscripts designate between-treatment differences in [3H]thymidine incorporation (P < 0-01;
Tukey mean comparisons). There was no treatment rIL-2 interaction (P > 005).
dValues represent c.p.m. + sem ( IO"3) for quadruplicate wells.
*Designates significant difference compared with other rIL-2 concentrations within column (P < 005;

Tukey).
"Designates within-row difference compared with the similar Mr fraction of CM (P

even

greater decrease in

cells

was

also observed

<

( 99 000 cells ml" '). The

005; Tukey).

presence of HCS in

phytohaemagglutinin- and pokeweed mitogen-stimulated cultures decreased the suppressor cell
subset by 12 000 and 16000cells ml"1, respectively, compared with stimulated controls. All
mitogen-stimulated cell populations contained a greater number of cells than did the control
cultures, but the T-cell population decreased below control culture levels when HCS was added to
the stimulated cultures ( 30 000 and 8000). The change in the approximate number of blast cells
detected by side and forward light scatter analysis correlated with that observed with final cell
concentration in the FACS cultures and with [3H]thymidine uptake data from the lymphocyte
proliferation assays (Fig. 4). Compared with phytohaemagglutinin- and pokeweed mitogen—

—

—

stimulated controls, the average percentage of blast cells in HCS-treated cultures decreased from
42-8 to 25-8% and from 42-2 to 8-9%, respectively.
Table 3. Fluorescence-activated cell sorter

analysis of horse lymphocytes

Treatment"
Monclonal

antibody

Control

HT23A (total T)
670 ± 55
77 + 11
HT14A(T subset)
191 + 10
IgG-FITC (B cells)
Change in cells ( IO3)
Change in cells ( 103)

Phytohaemagglutinin

Phytohaemagglutinin +

Pokeweed

Pokeweed +

706 ± 0-5
162 + 16
429 + 10
+ 36
+ 238

640 ± 40
150 + 28
409 + 17
-30
+ 218

681 ± 75
111 + 8
427 + 20
+ 11
+ 236

662 + 32
95 ±23
328 ± 8
-8
+ 137

Values represent average number of antibody-labelled cells ml"1 + sem (x 10"3) for two lymphocyte populations
and the average change in cell number compared with the control.
"Culture treatments are: Control no mitogen or HCS; phytohaemagglutinin phytohaemagglutinin-stimulated;
phytohaemagglutinin + phytohaemagglutinin-stimulated and HCS-2-treated; pokeweed pokeweed mitogenstimulated; Pokeweed + pokeweed mitogen-stimulated and HCS-2-treated.
=

=

-

=

=
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32

48

64

64r(b)

32

16

Forward scatter

4. Two-dimensional scatter analysis with side and forward light-scatter parameters was
used to compare blast cell populations in (a) untreated and (b) HCS-treated horse lymphocyte
cultures stimulated with pokeweed nitrogen. Gate settings were adjusted by comparing the
mitogen-stimulated control with unstimulated control, such that the window contained the
blast cells present only in the stimulated cell population. The same settings were then applied to
the two-dimensional scatter plot of the HCS-treated cell population. Window in (a) shows the
larger cells (blast cells, 33-3%) that were absent from the unstimulated cell population and in
(b) the percentage of blast cells (5-2%).

Fig.

Discussion

largely responsible for the actions of cell-mediated immunity and allograft rejection. The
early developing fetus and the protective placental tissue surrounding it express antigens that are
cells

are
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(Chatterjee-Hasrouni & Lala, 1979; Jenkinson & Owen, 1980; Billington &
et al, 1987). During successful pregnancies, fetal
do
initiate
cell-mediated
a
not
rejection response, even though immune cells are present at
antigens
the fetomaternal interface (Beer et al, 1975). An immunosuppressive substance (HCS) produced by
the horse conceptus and acting on cells may inhibit the T-cell response to fetal antigens, thereby
interfering with the otherwise eminent allograft rejection response. Maternal systemic immune
responses would be unaffected by the localized activity of HCS, which may explain why the
immune function of pregnant females is not compromised and anti-fetal antibodies are found in
maternal circulation of 90% of normal equine pregnancies (Allen et al, 1987), yet the conceptus
foreign

to

the mother

Burrows, 1986; Zuckerman & Head, 1986; Allen

remains unharmed.
Through the use of phytohaemagglutinin, a potent T-cell stimulator, pokeweed mitogen, a Tcell-dependent B-cell stimulator and lipopolysaccharide, a T-cell-independent B-cell stimulator
(Sharon, 1983; Jelinek & Lipsky, 1987), we have obtained evidence indicating that the T-cell popu¬
lation of horses is directly affected by HCS. Possibly owing to the potent stimulatory effect of
phytohaemagglutinin on cells, relatively high concentrations (10-20%) of HCS were required
before a decrease in cell proliferation was observed. Supporting evidence for the suppression of
cells by HCS was provided by FACS analysis which showed that the addition of HCS to
phytohaemagglutinin-stimulated cultures greatly decreased the number of cells, yet only slightly
affected
cells. In contrast to phytohaemagglutinin-stimulated cultures, pokeweed mitogenstimulated cells appeared to be highly vulnerable to HCS suppression as indicated by a rapid
decline in their proliferative response at very low HCS concentrations. The FACS data indicated
that in HCS-treated, pokeweed mitogen-stimulated cultures there was a dramatic decrease in the
number of cells. These results may be explained by the fact that B-cell proliferation depends on Tcell-derived lymphokines (Howard & Paul, 1983) and since pokeweed mitogen is a weak T-cell
stimulator, the absence of even a small portion of cells may have resulted in deficient lymphokine
production and a severe reduction of B-cell proliferation. The hypothesis that HCS does not act
directly on cells is further supported by the fact that HCS is ineffective at suppressing prolifer¬
ation of cultures stimulated with lipopolysaccharide. As lipopolysaccharide acts on cells without
a requirement for
cells, the effect of HCS on the T-cell population does not alter the B-cell
response to lipopolysaccharide. The overall effect of HCS on mitogen-stimulated blastogenesis is
most visually obvious in the FACS two-dimensional scatter analysis. Since light scatter parameters
allow the sorting of cells by size and density, the blast cells can be identified. The two-dimensional
scatter plot effectively demonstrates the decrease in blast cells when HCS is present in the culture.
Data from experiments relating to the temporal effect of HCS on stimulated lymphocytes sup¬
port the hypothesis that HCS inhibits lymphokine production, or lymphokine receptor function.
HCS is largely ineffective at suppressing cell proliferation if added 48 h after the start of stimu¬
lation. Since most cells have received both primary (mitogen) and secondary (lymphokine) stimu¬
lation by 48 h (Altman, 1990), these results indicate that HCS interferes with the initial steps of cell
activation and does not affect the later events involved in proliferation. Postponing HCS treatment
for 24 h appeared to allow the cells enough time to become activated by mitogen and to begin
producing lymphokines (Weiss et al, 1987). However, few of the cells had been fully stimulated by
the necessary lymphokine-receptor interaction and thus, HCS was effective. In addition, the fact
that HCS could suppress cells both 24 h after stimulation and in mixed lymphocyte reactions (see
preliminary assays) clearly indicates that suppressor activity is not simply due to the binding of
lectin by HCS components.
Although little is known about the effect of HCS on cells, we have shown that pretreatment of
cells for 24 h with HCS, followed by thorough rinsing, resulted in a cell population with full
proliferative capacity when subsequently stimulated with pokeweed mitogen. These data demon¬
strate that HCS is not cytotoxic and exhibits only a transient effect on lymphocyte proliferation.
In addition, the fact that HCS treatment does not show any long-term effect on responsiveness of
cells indicates that HCS suppression is not mediated through
suppressor cell recruitment or
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activation. The FACS data support this conclusion by demonstrating a decreased number of
suppressor cells in cultures treated with HCS.
Since the administration of antibodies to IL-2 in vivo can extend allograft acceptance (Kirkman
et al, 1985) and a high IL-2 can terminate pregnancy in mice (Lala et al, 1990), IL-2 may play an
integral role in allograft acceptance. Results from many studies have indicated that a relationship
exists between conceptus or uterine derived suppressor factors and IL-2 production (Segerson,
1988; Saito et al, 1990; Segerson & Gunsett, 1990; Segerson & Libby, 1990). We tested the hypoth¬
esis that the suppressive mechanism of HCS is mediated through the inhibition of IL-2 production.
Our initial attempt to overcome a potential deficiency of IL-2 in HCS-treated cultures, by sup¬
plementing the cultures with peripheral blood lymphocyte supernatant, was not particularly
effective. Since it has been shown that stimulated equine lymphocyte supernatant contains the
lymphokines required to stimulate IL-2-dependent cell responses (Magnuson et al, 1984), we
expected our peripheral blood lymphocyte supernatant to contain high levels of IL-2, but efforts to
detect it were unsuccessful because the murine-derived CTLL-2 cells did not respond to equine
peripheral blood lymphocyte supernatant.
Our attempt to override the suppressive activity of HCS by supplementing cultures with rIL-2
also proved unsuccessful. The fact that HCS suppressed proliferation of cells, even in the presence
of an overabundance of rIL-2, demonstrates that HCS suppression is not solely a result of deficient
IL-2 production. Furthermore, because the slopes of the treatment curves do not differ, we can
conclude that the suppressive activity of HCS remains the same, regardless of the high IL-2 concen¬
tration in the culture. Similarly, the relative difference between the phytohaemagglutinin and
phytohaemagglutinin + HCS curves (Fig. 3) remained constant at all levels of rIL-2 indicating that,
while the effect of rIL-2 was similar in both treatments, there were fewer cells that could respond
to the rIL-2 in the phytohaemagglutinin + HCS cultures. Because a suboptimal dose of phyto¬
haemagglutinin was used in the cultures, there was an IL-2 deficiency and the enhanced prolifer¬
ation observed in the rIL-2-supplemented cultures simply reflected the effect of sufficient IL-2 on
those cells not suppressed by HCS. One explanation for the inability of rIL-2 to overcome HCSinduced suppression is that HCS inhibits IL-2R activation; alternatively, HCS may be interfering
with the necessary interactions between IL-2 and IL-2R.
The latter hypothesis was tested using CTLL-2 cells that continuously express the high-affinity
IL-2R. While the Mr < 100 000 fraction of HCS inhibited CTLL-2 cell proliferation, possibly
owing to hormones or interferons produced by the horse conceptus or both, the Mr > 100 000
fraction containing HCS exerted no suppressive effect on the CTLL-2 cell response to rIL-2. The
fact that murine splenocytes are suppressed if treated with the same concentration of the
Mr > 100 000 fraction of HCS indicates that the ineffectiveness of HCS on CTLL-2 cells is not
simply due to species specificity of the suppressor factor. These results suggest that HCS interferes
with cellular events before the expression of the high-affinity IL-2R, but cannot suppress cell pro¬
liferation after IL-2R expression. However, it is possible that the CTLL-2 cells differ significantly
from cells found in vivo, and thus may not be vulnerable to the suppressor activity of HCS.
Together, the results from rIL-2 supplementation (Fig. 3 and Table 2) suggest that, in cultures
treated with HCS, there are fewer IL-2R-expressing cells that can respond to rIL-2 than in controls.
These results are in agreement with reports by Bulmer & Johnson (1986) who found that cells in
human decidua do not express IL-2Rs. It is not known whether IL-2R expression is inhibited by
HCS directly or indirectly through the interference of HCS with other early events in T-cell
activation. For example, suppression may result from an alteration in the production or function of
IL-1. Such a mechanism of suppression has been suggested for a human placental protein (Pockley

&Bolton, 1990).
We reported the production of an immunosuppressive factor produced by day 10 to day 26
horse conceptuses (Roth et al, 1990). In that study, the conceptus cultures were performed as
described here for obtaining HCS 1. In this study, we cultured day 20 conceptuses in medium
without FCS, thereby obtaining HCS 2. The immunosuppressive characteristics of HCS 1 and 2
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appear to be similar, indicating that supplementation of FCS to the culture medium is not required
> 100 000,
by horse conceptus tissue for the production of the suppressor factor. HCS has an
cells and seems to suppress
suppresses proliferation of
lymphocytes indirectly. This noncytotoxic suppressor factor is effective only if present during the early stages of lymphocyte acti¬
vation and its effect on cells is reversible. HCS suppression is highly dependent on its presence
during the early stages of cell activation and could explain why the suppressive factors are
produced as early as day 10 of pregnancy (Roth et al, 1990). Our results suggest that the factor(s)
suppress cell proliferation by preventing IL-2R activation. In view of the fact that cells are largely
responsible for allograft rejection, and the interaction between IL-2 and IL-2R is a prerequisite for
complete T-cell activation, we hypothesize that this suppressor factor disrupts the T-cell-mediated
allograft rejection that might otherwise terminate pregnancy by inhibiting IL-2R function.
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